Journal article

Fiblast (trafermin) in acute stroke: Results of the European-Australian phase II/III safety and efficacy trial

J Bogousslavsky, SJ Victor, EO Salinas, A Pallay, GA Donnan, C Fieschi, M Kaste, JM Orgogozo, A Chamorro, A Desmet

Cerebrovascular Diseases | KARGER | Published : 2002

DOI: 10.1159/000065683

Citation metrics

96Web of Science
105Scopus
105Dimensions

Keywords

Cardiovascular System & Cardiology
Basic Fibroblast Growth Factor
Recovery
Infarction
Stroke
Functional Recovery
Acute Ischemic Stroke
Randomized Controlled Trial
Infusions, Intravenous
Safety
Drug Administration Schedule
Humans
Neurosciences & Neurology
Science & Technology
Dose-Response Relationship, Drug
Acute Stroke
Life Sciences & Biomedicine
Peripheral Vascular Disease
Classification
Fibroblast-Growth-Factor
European-Australian Fiblast (trafermin) in Acute Stroke Group
Clinical Neurology
Neuroprotection Fiblast (trafermin)
Fibroblast Growth Factors
Double-Blind Method
Placebo
Expression
Peptide Fragments
Focal Cerebral-Ischemia
Factor Bfgf